These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Jaundice as a presenting manifestation of pediatric non-Hodgkin lymphoma: etiology, management, and outcome. Ghosh I; Bakhshi S J Pediatr Hematol Oncol; 2010 May; 32(4):e131-5. PubMed ID: 20445407 [TBL] [Abstract][Full Text] [Related]
3. Obstructive jaundice in Iran: factors affecting early outcome. Moghimi M; Marashi SA; Salehian MT; Sheikhvatan M Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):515-9. PubMed ID: 18842499 [TBL] [Abstract][Full Text] [Related]
4. Ovarian Non-Hodgkin's Lymphoma presenting as obstructive jaundice - a case report. Fadiora SO; Mabayoje VO; Oboro VO; Ojemakinde KA; Bello TO; Adeniji AA Niger Postgrad Med J; 2008 Sep; 15(3):197-9. PubMed ID: 18923596 [TBL] [Abstract][Full Text] [Related]
5. Primary non-Hodgkin's lymphoma of the common bile duct presenting as obstructive jaundice. Joo YE; Park CH; Lee WS; Kim HS; Choi SK; Cho CK; Rew JS; Kim SJ; Maetani I J Gastroenterol; 2004 Jul; 39(7):692-6. PubMed ID: 15293142 [TBL] [Abstract][Full Text] [Related]
7. Obstructive jaundice: an unusual initial manifestation of intra-abdominal non-Hodgkin lymphoma in a child. Ugur H; Tacyildiz N; Yavuz G; Unal E; Sayili A; Emir S; Kansu A; Kuloglu Z; Bahar K Pediatr Hematol Oncol; 2006; 23(1):87-90. PubMed ID: 16326418 [TBL] [Abstract][Full Text] [Related]
8. Clinical impact of biliary drainage and jaundice resolution in patients with obstructive metastases at the hilum. Van Laethem JL; De Broux S; Eisendrath P; Cremer M; Le Moine O; Devière J Am J Gastroenterol; 2003 Jun; 98(6):1271-7. PubMed ID: 12818268 [TBL] [Abstract][Full Text] [Related]
9. [Obstructive jaundice caused by hepatocellular carcinoma]. Nardello O; Farina GP; Cagetti M Ann Ital Chir; 2005; 76(6):535-41. PubMed ID: 16821515 [TBL] [Abstract][Full Text] [Related]
10. [Cholestatic icterus due to primary duodenal lymphoma]. Chat L; Mahi M; Chellaoui M; Benamour-Ammar H J Radiol; 2003 May; 84(5):617-9. PubMed ID: 13677829 [TBL] [Abstract][Full Text] [Related]
11. Endobiliary brush cytology during percutaneous transhepatic cholangiodrainage in patients with obstructive jaundice. Xing GS; Geng JC; Han XW; Dai JH; Wu CY Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):98-103. PubMed ID: 15730930 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous treatment of benign bile duct strictures. Köcher M; Cerná M; Havlík R; Král V; Gryga A; Duda M Eur J Radiol; 2007 May; 62(2):170-4. PubMed ID: 17383840 [TBL] [Abstract][Full Text] [Related]
13. Ovarian non-Hodgkin's lymphoma presenting as obstructive jaundice - a case report. Fadiora SO; Mabayoje VO; Oboro VO; Ojemakinde KA; Bello TO; Adeniji AA Niger Postgrad Med J; 2008 Dec; 15(4):267-9. PubMed ID: 19169347 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic difficulties and treatment of non-Hodgkin lymphoma of the orbit. Wanyura H; Uliasz M; Kaminski A; Samolczyk-Wanyura D; Smolarz-Wojnowska A J Craniomaxillofac Surg; 2007 Jan; 35(1):39-47. PubMed ID: 17267230 [TBL] [Abstract][Full Text] [Related]
15. Endo-laparoscopic approach in the management of obstructive jaundice and malignant gastric outflow obstruction. Tang CN; Siu WT; Ha JP; Li MK Hepatogastroenterology; 2005; 52(61):128-34. PubMed ID: 15783012 [TBL] [Abstract][Full Text] [Related]
16. Left hepatic trisectionectomy for hepatobiliary malignancies. Lang H; Sotiropoulos GC; Brokalaki EI; Radtke A; Frilling A; Molmenti EP; Malagó M; Broelsch CE J Am Coll Surg; 2006 Sep; 203(3):311-21. PubMed ID: 16931303 [TBL] [Abstract][Full Text] [Related]
17. Primary biliary B-cell lymphoma of the cystic duct causing obstructive jaundice. Jho DH; Jho DJ; Chejfec G; Ahn M; Ong ES; Espat NJ Am Surg; 2007 May; 73(5):508-10. PubMed ID: 17521008 [TBL] [Abstract][Full Text] [Related]
19. Interventional therapy of malignant obstructive jaundice. Feng GH; Cai Y; Jia Z; Yang DQ; Chen H; Jin HC; Yu QH; Zhu W; Wang CX Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):300-2. PubMed ID: 14599989 [TBL] [Abstract][Full Text] [Related]
20. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group. Attarbaschi A; Dworzak M; Steiner M; Urban C; Fink FM; Reiter A; Gadner H; Mann G Pediatr Blood Cancer; 2005 Jan; 44(1):70-6. PubMed ID: 15368550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]